Latest news
Did Novo’s phase 3 flop kill the inflammation hypothesis in heart disease? - Pharma VoicePharma Voice · Mon, 10 Aug 2026 13:30:27 GMTOutcome of 'Zeus' Trial Throws Wrench in Heart Disease Theory - NewserNewser · Sat, 08 Aug 2026 11:30:00 GMTLGVN Stock Slips After Hours As FDA Flags Concerns On Rare Heart Defect Trial Design - StocktwitsStocktwits · Fri, 07 Aug 2026 04:52:30 GMTNovo setback casts doubt on a new way to treat heart disease - BioPharma DiveBioPharma Dive · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMT